oxybutynin has been researched along with Bladder Cancer in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kamali, K | 1 |
| Nikbakht, J | 1 |
| Ayubi, E | 1 |
| Nabizadeh, M | 1 |
| Sarhadi, S | 1 |
| Johnson, MH | 1 |
| Nepple, KG | 1 |
| Peck, V | 1 |
| Trinkaus, K | 1 |
| Klim, A | 1 |
| Sandhu, GS | 1 |
| Kibel, AS | 1 |
| Patel, HR | 1 |
| Albehussi, S | 1 |
| Arya, M | 1 |
| Miller, RA | 1 |
2 trials available for oxybutynin and Bladder Cancer
| Article | Year |
|---|---|
Comparison of the Efficacy of Oxybutynin, Phenazopyridine, Celecoxib, and Placebo in the Treatment of Urinary Tract Symptoms after BCG Therapy in Patients with Bladder Tumors.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; BCG Vaccine; Celecoxib; Female; Humans; | 2020 |
Randomized controlled trial of oxybutynin extended release versus placebo for urinary symptoms during intravesical Bacillus Calmette-Guérin treatment.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Aged; BCG Vaccine; Carcinoma, Transitional Cel | 2013 |
1 other study available for oxybutynin and Bladder Cancer
| Article | Year |
|---|---|
Can oxybutynin cause peripheral neuropathy?
Topics: Administration, Intravesical; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; | 2002 |